Insider Trading activities of Transdel Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Transdel Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Transdel Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Transdel Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is IMMY. The reporting company's CIK number is 1360214.
The total value of stock buying since 2005 is $1,008,156.
The total value of stock sales since 2005 is $3,310,750.
The total value of stock option exercises since 2005 is $813,182.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Transdel Pharmaceuticals Inc (IMMY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-07 0 $0 10,000 $30,530 0 $0
2016-12 295,000 $528,050 0 $0 200,000 $344,000
2016-03 45,000 $164,250 0 $0 0 $0
2016-02 0 $0 0 $0 15,000 $55,200
2015-06 35,000 $276,500 0 $0 0 $0
2015-05 2,801 $22,408 410,000 $3,280,220 0 $0
2015-04 0 $0 0 $0 15,282 $90,545
2014-09 0 $0 0 $0 71,875 $323,437
2008-09 7,900 $9,640 0 $0 0 $0
2008-06 4,200 $7,308 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Transdel Pharmaceuticals Inc insiders (IMMY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-07-17 Kammer Robert J Sale 10,000 3.05 30,530
2016-12-19 Boll Andrew R. (Chief Financial Officer) Buy 39,000 1.79 69,810
2016-12-19 Baum Mark L (Chief Executive Officer) Buy 156,000 1.79 279,240
2016-12-19 Baum Mark L (Chief Executive Officer) Option Ex 200,000 1.72 344,000
2016-12-19 Lindstrom Richard L Md Buy 100,000 1.79 179,000
2016-03-11 Opaleye Management Inc. Buy 45,000 3.65 164,250
2016-02-01 Boll Andrew R. (Chief Financial Officer) Option Ex 15,000 3.68 55,200
2015-06-30 Opaleye Management Inc. Buy 35,000 7.90 276,500
2015-05-19 Opaleye Management Inc. Buy 2,801 8.00 22,408
2015-05-19 Miloni Donald Paul Sale 110,000 8.00 880,220
2015-05-18 Miloni Donald Paul Sale 300,000 8.00 2,400,000
2015-04-23 Kammer Robert J Option Ex 15,282 5.92 90,545
2014-09-30 Kammer Robert J Option Ex 71,875 4.50 323,437
2008-09-29 Singh Juliet (CEO, Director and President) Buy 500 1.40 700
2008-09-26 Singh Juliet (CEO, Director and President) Buy 500 1.40 700
2008-09-25 Thornley Anthony S (Director) Buy 3,000 1.05 3,150
2008-09-23 Thornley Anthony S (Director) Buy 3,000 1.25 3,750
2008-09-10 Thornley Anthony S (Director) Buy 500 1.42 710
2008-09-03 Thornley Anthony S (Director) Buy 200 1.65 330
2008-09-02 Thornley Anthony S (Director) Buy 200 1.50 300
2008-06-27 Thornley Anthony S (Director) Buy 4,200 1.74 7,308

Insider trading activities including stock purchases, stock sales, and option exercises of IMMY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Transdel Pharmaceuticals Inc (symbol IMMY, CIK number 1360214) see the Securities and Exchange Commission (SEC) website.